Oric Pharmaceuticals earnings were -$132.9M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ORIC earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$30.0M, down 17.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ORIC reported annual earnings of -$127.8M, with 27% growth.
Oric Pharmaceuticals Earnings Reports & History FAQ
What were Oric Pharmaceuticals's earnings last quarter?
On ORIC's earnings call on Invalid Date, Oric Pharmaceuticals (NASDAQ: ORIC) reported Q1 2025 earnings per share (EPS) of -$0.42, up 13.51% year over year. Total ORIC earnings for the quarter were -$30.02 million. In the same quarter last year, Oric Pharmaceuticals's earnings per share (EPS) was -$0.37.
Is Oric Pharmaceuticals profitable or losing money?
As of the last Oric Pharmaceuticals earnings report, Oric Pharmaceuticals is currently losing money. Oric Pharmaceuticals's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$132.86 million, a 30.56% increase year over year.
What was ORIC's earnings growth in the past year?
As of Oric Pharmaceuticals's earnings date in Invalid Date, Oric Pharmaceuticals's earnings has grown year over year. ORIC earnings in the past year totalled -$132.86 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.